Dr T. Kishan Subudhi

Dr T. Kishan Subudhi

Assistant Professor
Nuclear Medicine

nucmed_tkishan@aiimsbhubaneswar.edu.in

Biosketch

15

PUBLICATIONS

0

CITATIONS

0

H INDEX

PERSONAL INFORMATION

Dr T. Kishan Subudhi

Assistant Professor

Nuclear Medicine

Degree / Diploma Year of Passing Subject Name of the University/ Institution
MBBS 2014 Berhampur, Ganjam, ODISHA
MD 2020 Nuclear Medicine AIIMS, New Delhi
  • To explore various radiophrmaceuticals in different malignancies and find their therapeutic implication and provide precision medicine to the patients.
  • Thyroid, prostate carcinoma and neuroendocrine tumor treatment with radioiodine, RLT and PRRT.

  1. Subudhi, T. K., Damle, N. A., Arora, G., Prabhu, M., Tripathi, M., Bal, C., Agarwal, S., Kumar, R., Kumar, R., & Madan, K. (2022). Ga-68 Prostate-Specific Membrane Antigen-HBED-CC Positron Emission Tomography/Computed Tomography in Anaplastic Thyroid Carcinoma. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 37(4), 310–317. https://doi.org/10.4103/ijnm.ijnm_21_22
  2. Tripathy, S., Parida, G. K., Naswa, N., Subudhi, K., Sreedharan Thankarajan, A. R., & Reddy, S. (2019). Elastofibroma Dorsi: Findings on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 34(3), 258–259. https://doi.org/10.4103/ijnm.IJNM_6_19
  3. Damle, N., Kaushik, P., Subudhi, K., Tiwari, V., Sikdar, S., Ranjan, P., & Goyal, A. (2023). Tc-99m Ethambutol Scintigraphy with Single-Photon Emission Computed Tomography in Diagnosis of Tubercular Iliopsoas Abscess. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 38(4), 390–391. https://doi.org/10.4103/ijnm.ijnm_198_22
  4. Tripathy, S., Behera, A., Kumar, A., Subudhi, K., & Bal, C. (2020). Adrenocortical Carcinoma with Inferior Vena Cava Thrombus on 18F-FDG-PET-Computed Tomography. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 35(1), 87–88. https://doi.org/10.4103/ijnm.IJNM_107_19
  5. Passah, A., Arora, S., Damle, N. A., Tripathi, M., Bal, C., Subudhi, T. K., & Arora, G. (2018). 68Ga-Prostate-Specific Membrane Antigen PET/CT in Triple-Negative Breast Cancer. Clinical nuclear medicine, 43(6), 460–461. https://doi.org/10.1097/RLU.0000000000002071
  6. G B, P., Damle, N. A., Reddy K, R., Tandon, N., Naranje, P., Kandasamy, D., & Subudhi, K. (2024). 68 Ga-DOTANOC PET/CT in 2 Siblings With Von Hippel-Lindau Disease. Clinical nuclear medicine, 49(6), e266–e268. https://doi.org/10.1097/RLU.0000000000005180
  7. Tripathy, S., Mirdha, A. R., Shamim, S. A., Parida, G. K., & Subudhi, K. (2020). A Case of Metachronous Triple Carcinoma with Synchronous Double Primary Carcinoma on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 35(2), 174–175. https://doi.org/10.4103/ijnm.IJNM_19_19
  8. Agarwal, S., Kakkar, A., Damle, N. A., Kumar, C., Sarangi, J., Subudhi, K., Jain, D., & Sharma, M. C. (2020). SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss. Pathology, research and practice, 216(4), 152830. https://doi.org/10.1016/j.prp.2020.152830
  9. Yadav, D., Angamuthu, M., Subudhi, T. K., Das, C. J., & Kumar, R. (2020). PET/CT in Evaluation of Low Backache Due to Sacral Nerve Root Involvement: Inflammatory and Malignant Involvement. Clinical nuclear medicine, 45(6), e299–e300. https://doi.org/10.1097/RLU.0000000000003021
  10. Tripathy, S., Aggrawal, S., Subudhi, K., Kumar, R., & Narwal, A. (2019). Calcitonin-Negative Neuroendocrine Tumor of the Thyroid on 68Ga DOTANOC PET-CT. Clinical nuclear medicine, 44(9), e546–e547. https://doi.org/10.1097/RLU.0000000000002698
  11. Aggarwal, P., Krishna Kumar, R. G., Das, C. J., Kubihal, V., Subudhi, T. K., Khan, M. A., & Kumar, R. (2024). Role of non-contrast CT component of prostate-specific membrane antigen PET/CT scan in the detection of peripheral zone prostate cancer. The British journal of radiology, 97(1153), 195–200. https://doi.org/10.1093/bjr/tqad009
  12. Tripathy, S., Arun Raj, S. T., Subudhi, K., Kaushik, P., & Kumar, R. (2020). Low-Grade Thymoma with Osseous and Pulmonary Metastases: Role of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Initial Staging. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 35(2), 185–186. https://doi.org/10.4103/ijnm.IJNM_160_19
  13. Tripathy, S., Subudhi, T. K., & Kumar, R. (2019). Stoma Site Infection Mimicking Lymphoma Recurrence: Potential Pitfall on 18F FDG Positron Emission Tomography-Computed Tomography. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 34(3), 233–234. https://doi.org/10.4103/ijnm.IJNM_5_19
  14. Jaleel, J., Subudhi, T. K., Sagar, S., Yadav, R., Tripathi, M., & Bal, C. (2023). Incidentally Detected Gastrointestinal Stromal Tumor in a Patient with Carcinoma Prostate: 68Ga-Prostate-Specific Membrane Antigen Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 38(1), 67–68. https://doi.org/10.4103/ijnm.ijnm_105_22
  15. Rehman, A., Singhal, T., Singh, P., Parida, G. K., Agrawal, K., Patro, P. S. S., Subudhi, T. K., & Gupta, S. (2024). Steroid-induced Activated White Adipose Tissue on FDG PET-CT. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 39(5), 409–410. https://doi.org/10.4103/ijnm.ijnm_94_24

 

Dr T. Kishan Subudhi

Orcid ID
Scopus ID

Scopus ID
GS Image

Google Scholar ID
Researchgate ID

Researchgate ID
EXPERTISE INFORMATION
Areas of Interest
    • To explore various radiophrmaceuticals in different malignancies and find their therapeutic implication and provide precision medicine to the patients.
    • Thyroid, prostate carcinoma and neuroendocrine tumor treatment with radioiodine, RLT and PRRT.